SUSAN HILSENBECK

Concepts (1182)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
185
2024
2542
6.890
Why?
Receptors, Estrogen
64
2024
796
2.140
Why?
Receptor, ErbB-2
35
2023
519
1.880
Why?
Tamoxifen
30
2020
364
1.710
Why?
Antineoplastic Agents, Hormonal
25
2021
257
1.620
Why?
Drug Resistance, Neoplasm
32
2024
745
1.470
Why?
Triple Negative Breast Neoplasms
10
2024
242
1.230
Why?
Gene Expression Regulation, Neoplastic
45
2021
1987
1.220
Why?
Gene Expression Profiling
41
2021
1789
1.210
Why?
Antineoplastic Agents
34
2023
1725
1.180
Why?
Biomarkers, Tumor
36
2024
1559
1.140
Why?
Signal Transduction
45
2021
4638
1.020
Why?
Receptors, Progesterone
30
2021
877
1.010
Why?
Cell Line, Tumor
56
2024
3449
0.990
Why?
Antineoplastic Combined Chemotherapy Protocols
23
2024
1262
0.960
Why?
Female
242
2025
67333
0.930
Why?
Mammary Neoplasms, Experimental
22
2017
243
0.930
Why?
Mammary Glands, Animal
17
2022
476
0.910
Why?
Estrogen Receptor alpha
17
2021
454
0.900
Why?
Oligonucleotide Array Sequence Analysis
26
2014
1038
0.840
Why?
Humans
304
2025
126330
0.810
Why?
Neoplasms
19
2024
2807
0.790
Why?
Genomics
7
2018
1538
0.790
Why?
Quinazolines
16
2023
174
0.780
Why?
Cell Proliferation
33
2024
2394
0.750
Why?
Mice
102
2025
17881
0.740
Why?
Neoadjuvant Therapy
21
2023
347
0.710
Why?
Bayes Theorem
3
2024
288
0.690
Why?
Animals
123
2025
34533
0.690
Why?
Neoplasm Staging
25
2022
1291
0.680
Why?
Neoplasm Metastasis
17
2025
711
0.660
Why?
Xenograft Model Antitumor Assays
20
2024
921
0.650
Why?
Mammary Neoplasms, Animal
6
2022
138
0.650
Why?
Cell Transformation, Neoplastic
17
2022
625
0.630
Why?
Prognosis
59
2021
4742
0.630
Why?
Models, Statistical
5
2018
479
0.600
Why?
Estradiol
17
2020
528
0.590
Why?
Apoptosis
29
2024
1839
0.590
Why?
Information Dissemination
4
2014
188
0.590
Why?
Genetic Testing
7
2017
1021
0.590
Why?
Neoplasm Recurrence, Local
15
2022
1171
0.580
Why?
ErbB Receptors
12
2021
287
0.570
Why?
Survival Analysis
23
2020
1517
0.550
Why?
Ovarian Neoplasms
8
2011
424
0.550
Why?
Uterine Cervical Neoplasms
8
2023
236
0.550
Why?
Neoplastic Stem Cells
9
2015
328
0.540
Why?
Taxoids
12
2017
68
0.540
Why?
Mammary Tumor Virus, Mouse
13
2018
106
0.530
Why?
Transcription Factor AP-1
9
2016
108
0.520
Why?
Precancerous Conditions
7
2018
282
0.520
Why?
Middle Aged
90
2025
27031
0.510
Why?
STAT5 Transcription Factor
5
2022
89
0.510
Why?
Estrogens
12
2020
504
0.500
Why?
Mice, Nude
26
2021
723
0.490
Why?
Epithelial Cells
13
2022
913
0.480
Why?
STAT3 Transcription Factor
6
2015
219
0.480
Why?
Adenocarcinoma
12
2024
1029
0.470
Why?
Data Interpretation, Statistical
2
2012
234
0.460
Why?
Carcinoma, Ductal, Breast
7
2015
86
0.450
Why?
Genetic Counseling
2
2018
225
0.450
Why?
Tumor Suppressor Protein p53
14
2015
747
0.450
Why?
Gene Expression
13
2020
1560
0.450
Why?
Chemotherapy, Adjuvant
9
2017
369
0.440
Why?
Breast
9
2022
212
0.430
Why?
Mutation
23
2021
5965
0.420
Why?
Trastuzumab
14
2023
136
0.410
Why?
Aged
66
2025
19962
0.410
Why?
Molecular Targeted Therapy
6
2020
379
0.410
Why?
Biomedical Research
3
2021
526
0.410
Why?
Adult
74
2024
29802
0.400
Why?
Cyclin-Dependent Kinase 6
2
2024
44
0.400
Why?
Cyclin-Dependent Kinase 4
2
2024
59
0.400
Why?
Aromatase Inhibitors
4
2020
76
0.390
Why?
Tumor Cells, Cultured
28
2021
1064
0.390
Why?
Receptors, G-Protein-Coupled
5
2021
298
0.390
Why?
Stem Cells
6
2018
715
0.380
Why?
Carcinoma, Intraductal, Noninfiltrating
4
2021
65
0.380
Why?
Tetrahydronaphthalenes
6
2009
29
0.370
Why?
Phosphorylation
15
2021
1640
0.360
Why?
Anticarcinogenic Agents
8
2009
53
0.350
Why?
Estrogen Antagonists
6
2020
103
0.350
Why?
Receptors, Androgen
4
2025
415
0.350
Why?
Risk Management
1
2011
68
0.340
Why?
Randomized Controlled Trials as Topic
4
2020
1129
0.340
Why?
Pyrazoles
3
2025
313
0.330
Why?
Mice, Transgenic
25
2018
2428
0.330
Why?
Interleukin-8
3
2016
211
0.330
Why?
Neoplasms, Hormone-Dependent
6
2018
101
0.330
Why?
Pancreatic Neoplasms
6
2024
698
0.320
Why?
Disease-Free Survival
16
2017
891
0.320
Why?
Treatment Outcome
39
2025
12380
0.320
Why?
Research Design
7
2016
709
0.320
Why?
Disease Models, Animal
19
2021
4467
0.310
Why?
Lung Neoplasms
12
2023
1668
0.310
Why?
Lymphatic Metastasis
19
2013
420
0.300
Why?
Neoplasm Transplantation
16
2021
387
0.300
Why?
Consumer Health Information
1
2009
26
0.300
Why?
Medical Oncology
3
2021
224
0.300
Why?
Protein Kinase Inhibitors
6
2024
558
0.300
Why?
Ethics, Medical
1
2011
398
0.300
Why?
PTEN Phosphohydrolase
3
2017
260
0.300
Why?
Mastectomy
7
2017
67
0.300
Why?
Community Participation
1
2009
42
0.300
Why?
Receptor, Fibroblast Growth Factor, Type 1
3
2015
67
0.300
Why?
Public Opinion
1
2009
57
0.300
Why?
Papillomavirus Infections
2
2023
296
0.290
Why?
Insulin-Like Growth Factor I
7
2011
343
0.290
Why?
Repressor Proteins
5
2014
833
0.290
Why?
Nuclear Receptor Coactivators
3
2014
72
0.290
Why?
Arthralgia
2
2019
56
0.290
Why?
Transcriptome
6
2019
1013
0.290
Why?
Cell Division
19
2013
762
0.290
Why?
Antineoplastic Agents, Phytogenic
8
2005
102
0.290
Why?
Neoplasms, Experimental
5
2017
218
0.290
Why?
Computer Terminals
1
2007
2
0.290
Why?
Asthenopia
1
2007
2
0.290
Why?
Eye Protective Devices
1
2007
7
0.290
Why?
Paclitaxel
8
2024
128
0.290
Why?
DNA Repair
4
2019
589
0.280
Why?
RNA, Messenger
20
2023
2818
0.280
Why?
Genes, BRCA1
4
2012
50
0.280
Why?
Ophthalmic Solutions
1
2007
92
0.270
Why?
Breast Diseases
2
2016
35
0.270
Why?
Neoplasm Invasiveness
12
2021
625
0.270
Why?
Physician's Role
1
2009
171
0.270
Why?
Internet
2
2009
378
0.270
Why?
Epithelial-Mesenchymal Transition
3
2017
219
0.270
Why?
Health Knowledge, Attitudes, Practice
3
2024
858
0.260
Why?
Social Support
1
2009
350
0.260
Why?
Aged, 80 and over
22
2025
6645
0.260
Why?
Pyridines
4
2024
240
0.260
Why?
Gene Expression Regulation
12
2016
2549
0.250
Why?
Kaplan-Meier Estimate
11
2021
1073
0.250
Why?
Mice, SCID
9
2021
595
0.250
Why?
Tears
1
2007
172
0.250
Why?
Clinical Trials as Topic
8
2015
1111
0.250
Why?
Class I Phosphatidylinositol 3-Kinases
4
2023
76
0.250
Why?
Transcription, Genetic
9
2017
1716
0.250
Why?
Male
57
2025
62031
0.250
Why?
Interleukin-6
4
2017
421
0.250
Why?
Janus Kinase 2
2
2018
131
0.240
Why?
Pancreatectomy
4
2010
139
0.240
Why?
Antibodies, Monoclonal, Humanized
10
2020
515
0.240
Why?
Nuclear Receptor Coactivator 3
5
2016
348
0.240
Why?
Androgen Receptor Antagonists
1
2025
36
0.240
Why?
Protein Tyrosine Phosphatase, Non-Receptor Type 12
2
2018
19
0.240
Why?
MCF-7 Cells
7
2020
224
0.230
Why?
Informed Consent
4
2013
336
0.230
Why?
Viral Tropism
1
2025
43
0.230
Why?
Computer Simulation
2
2016
664
0.230
Why?
Promoter Regions, Genetic
8
2016
1342
0.230
Why?
Ki-67 Antigen
6
2014
115
0.230
Why?
Phosphatidylinositol 3-Kinases
5
2019
342
0.230
Why?
Cell Movement
9
2021
856
0.220
Why?
Carcinoma, Lobular
3
2010
24
0.220
Why?
Neoplasm Proteins
6
2016
685
0.220
Why?
Prostatic Neoplasms, Castration-Resistant
1
2025
89
0.220
Why?
Pyrophosphatases
1
2024
21
0.220
Why?
Genes, p53
7
2004
217
0.220
Why?
Time Factors
21
2021
6334
0.220
Why?
Wnt1 Protein
4
2018
72
0.220
Why?
Dry Eye Syndromes
1
2007
271
0.220
Why?
Protein Array Analysis
4
2018
102
0.220
Why?
Neurofibromin 1
2
2023
42
0.220
Why?
Dependovirus
1
2025
129
0.210
Why?
Prostatic Neoplasms
5
2017
1551
0.210
Why?
Germ-Line Mutation
2
2024
343
0.210
Why?
Keratin-6
2
2015
13
0.210
Why?
Oncolytic Viruses
1
2024
73
0.210
Why?
DNA Methylation
4
2022
1073
0.210
Why?
Cell Survival
11
2021
835
0.210
Why?
Piperazines
2
2024
242
0.210
Why?
Follow-Up Studies
13
2020
5204
0.200
Why?
Progesterone
4
2017
621
0.200
Why?
Proteogenomics
1
2023
69
0.200
Why?
Genetic Vectors
4
2025
942
0.200
Why?
Reverse Transcriptase Polymerase Chain Reaction
14
2010
1300
0.200
Why?
Antibodies, Monoclonal
5
2010
1026
0.200
Why?
Transfection
15
2013
1073
0.190
Why?
Carrier Proteins
4
2014
1029
0.190
Why?
Genetic Research
2
2013
55
0.190
Why?
Tumor Stem Cell Assay
10
2011
36
0.190
Why?
Thrombocytopenia
1
2024
225
0.190
Why?
Antimetabolites, Antineoplastic
3
2018
185
0.190
Why?
Emphysema
2
2014
68
0.190
Why?
Proportional Hazards Models
14
2014
1380
0.190
Why?
Heat-Shock Proteins
6
2001
197
0.190
Why?
Pleural Neoplasms
1
2023
71
0.190
Why?
Cell Cycle
10
2016
612
0.190
Why?
Protein Tyrosine Phosphatases
2
2016
78
0.190
Why?
Cisplatin
5
2017
251
0.190
Why?
Cluster Analysis
4
2018
409
0.190
Why?
DNA, Neoplasm
9
2012
305
0.190
Why?
S Phase
5
1998
74
0.190
Why?
Mesothelioma
1
2023
89
0.180
Why?
Tumor Microenvironment
5
2024
580
0.180
Why?
Metformin
1
2023
153
0.180
Why?
Financing, Organized
1
2021
20
0.180
Why?
Genetic Privacy
2
2011
42
0.180
Why?
Minority Groups
2
2020
243
0.180
Why?
Tumor Suppressor Proteins
3
2017
475
0.180
Why?
Brain Neoplasms
3
2020
1324
0.180
Why?
Dose-Response Relationship, Drug
14
2021
1685
0.180
Why?
Genome, Human
4
2011
1304
0.180
Why?
Health Care Surveys
3
2011
285
0.170
Why?
Immunohistochemistry
14
2015
1712
0.170
Why?
Tenascin
2
2017
31
0.170
Why?
Transplantation, Heterologous
13
2011
260
0.170
Why?
Algorithms
5
2022
1647
0.170
Why?
Up-Regulation
5
2015
874
0.170
Why?
Abdomen
4
1997
127
0.170
Why?
Transcription Factors
8
2019
2618
0.170
Why?
Pancreaticoduodenectomy
2
2011
93
0.170
Why?
Retrospective Studies
26
2023
16517
0.170
Why?
Heterografts
5
2021
181
0.170
Why?
Aging
4
2001
1208
0.170
Why?
Gene Amplification
3
2019
236
0.170
Why?
Biomarkers
8
2021
3153
0.170
Why?
Indoles
2
2018
192
0.170
Why?
Predictive Value of Tests
10
2013
2194
0.170
Why?
Wnt Proteins
1
2021
217
0.170
Why?
Anemia
1
2024
344
0.170
Why?
Genes, erbB-2
6
2010
37
0.170
Why?
Research Personnel
1
2021
120
0.170
Why?
Genes, Tumor Suppressor
3
2021
214
0.170
Why?
Methylphenidate
1
2020
58
0.170
Why?
RNA, Small Interfering
8
2016
677
0.170
Why?
Mitogen-Activated Protein Kinases
6
2014
210
0.160
Why?
Disclosure
2
2018
150
0.160
Why?
Blotting, Western
11
2010
1110
0.160
Why?
Postoperative Complications
8
2013
3078
0.160
Why?
Hypothalamic Diseases
1
2020
37
0.160
Why?
Carcinogenesis
4
2015
345
0.160
Why?
Tissue Array Analysis
6
2021
137
0.160
Why?
GTPase-Activating Proteins
2
2010
89
0.160
Why?
Mevalonic Acid
1
2019
20
0.160
Why?
Research Subjects
2
2013
54
0.160
Why?
Hepatocyte Nuclear Factor 3-alpha
2
2016
48
0.160
Why?
TOR Serine-Threonine Kinases
3
2018
438
0.160
Why?
Parents
2
2018
1028
0.160
Why?
Cholecalciferol
1
2019
24
0.160
Why?
Smoking
4
2014
1050
0.160
Why?
Central Nervous System Stimulants
1
2020
127
0.160
Why?
Pancreatic Fistula
2
2010
29
0.160
Why?
Selective Estrogen Receptor Modulators
4
2011
60
0.160
Why?
Mice, Inbred C57BL
13
2018
4466
0.160
Why?
Safety-net Providers
1
2020
52
0.160
Why?
Mice, Inbred NOD
5
2021
307
0.160
Why?
Lymph Nodes
4
1997
380
0.160
Why?
Consent Forms
2
2011
22
0.160
Why?
Lymphocytes, Tumor-Infiltrating
1
2019
124
0.150
Why?
Cinnamates
1
2018
15
0.150
Why?
Estrogen Receptor Modulators
3
2004
38
0.150
Why?
Young Adult
9
2024
9174
0.150
Why?
Trans-Activators
6
2005
807
0.150
Why?
Head and Neck Neoplasms
1
2023
502
0.150
Why?
Transgenes
6
2025
336
0.150
Why?
Databases, Factual
4
2019
1193
0.150
Why?
Oncologists
1
2018
29
0.150
Why?
Protons
1
2018
94
0.150
Why?
Exome
2
2024
1039
0.150
Why?
Colorectal Neoplasms
3
2020
581
0.150
Why?
Camptothecin
5
1999
73
0.150
Why?
Craniospinal Irradiation
1
2018
65
0.140
Why?
Histone Deacetylases
2
2011
115
0.140
Why?
Lymphocytes
1
2019
409
0.140
Why?
Bacterial Proteins
4
2019
901
0.140
Why?
Hypothyroidism
1
2018
95
0.140
Why?
Promyelocytic Leukemia Protein
1
2017
12
0.140
Why?
Survival Rate
13
2010
2070
0.140
Why?
Nuclear Proteins
6
2014
1280
0.140
Why?
Zinc Finger Protein GLI1
1
2017
36
0.140
Why?
Cytochrome P-450 CYP2D6
1
2017
31
0.140
Why?
Nanocapsules
1
2017
8
0.140
Why?
Receptors, Calcitriol
1
2017
70
0.140
Why?
Claudins
2
2014
29
0.140
Why?
Receptors, Cell Surface
2
2018
480
0.140
Why?
Nanotubes, Carbon
1
2017
19
0.140
Why?
Societies, Medical
1
2021
709
0.140
Why?
I-kappa B Kinase
1
2017
62
0.140
Why?
Genes, BRCA2
2
2011
41
0.140
Why?
Urokinase-Type Plasminogen Activator
1
1997
38
0.140
Why?
Surveys and Questionnaires
7
2024
3716
0.140
Why?
Integrins
1
2017
98
0.140
Why?
Carcinoma, Squamous Cell
2
1992
665
0.140
Why?
Texas
10
2024
3587
0.140
Why?
Disease Progression
7
2021
2103
0.130
Why?
Paracrine Communication
1
2017
73
0.130
Why?
Weight Loss
2
2020
491
0.130
Why?
Plasminogen Activator Inhibitor 1
1
1997
47
0.130
Why?
Interleukin-1beta
1
2017
164
0.130
Why?
Cancer Survivors
1
2020
216
0.130
Why?
Alopecia
1
2017
39
0.130
Why?
Proto-Oncogene Proteins c-jun
6
2008
36
0.130
Why?
Carcinoma
4
1992
290
0.130
Why?
CELF1 Protein
1
2016
49
0.130
Why?
Mitogen-Activated Protein Kinase Phosphatases
1
2016
15
0.130
Why?
DNA Damage
2
2019
517
0.130
Why?
Methotrexate
1
2018
336
0.130
Why?
Dual-Specificity Phosphatases
1
2016
21
0.130
Why?
Syndrome
2
2011
1122
0.130
Why?
Scalp
1
2017
57
0.130
Why?
Leukemia, Myeloid, Acute
1
2022
539
0.130
Why?
Amyloid beta-Peptides
1
2018
215
0.130
Why?
Clinical Trials, Phase I as Topic
1
2016
62
0.130
Why?
SOXC Transcription Factors
1
2016
10
0.130
Why?
Stromal Cells
2
2015
305
0.130
Why?
Down-Regulation
6
2016
689
0.130
Why?
Biopsy, Large-Core Needle
1
2016
32
0.130
Why?
Genes, myc
2
2011
105
0.130
Why?
Doxorubicin
5
2015
290
0.130
Why?
Drug-Related Side Effects and Adverse Reactions
1
2018
262
0.120
Why?
GTP-Binding Protein alpha Subunit, Gi2
1
2015
5
0.120
Why?
Calcium-Calmodulin-Dependent Protein Kinase Kinase
1
2016
51
0.120
Why?
Adolescent
14
2024
19548
0.120
Why?
Triazines
3
2010
30
0.120
Why?
Receptor, Fibroblast Growth Factor, Type 2
2
2013
34
0.120
Why?
E2F1 Transcription Factor
1
2016
49
0.120
Why?
Reproducibility of Results
6
2020
2900
0.120
Why?
Phosphoric Monoester Hydrolases
1
2016
103
0.120
Why?
Proinsulin
1
2015
12
0.120
Why?
Hypothermia, Induced
1
2017
169
0.120
Why?
Osteopontin
2
2014
50
0.120
Why?
Bone and Bones
1
2017
271
0.120
Why?
Calmodulin
1
2016
224
0.120
Why?
Cell Nucleus
3
2020
673
0.120
Why?
Mice, Knockout
10
2015
3777
0.120
Why?
Intracellular Signaling Peptides and Proteins
2
2017
564
0.120
Why?
Risk Factors
16
2019
10375
0.120
Why?
Fluorouracil
5
2014
130
0.120
Why?
Proto-Oncogene Proteins c-bcl-2
4
2021
177
0.120
Why?
Anthracyclines
2
2017
38
0.120
Why?
Bone Neoplasms
3
2017
430
0.120
Why?
Multivariate Analysis
7
2012
1436
0.120
Why?
Healthcare Disparities
1
2020
446
0.120
Why?
Prospective Studies
10
2023
6175
0.120
Why?
Genes, Regulator
2
2006
56
0.120
Why?
Medulloblastoma
2
2018
550
0.120
Why?
Fibroblasts
2
2016
888
0.120
Why?
Adipose Tissue
2
2015
470
0.120
Why?
GATA2 Transcription Factor
1
2014
39
0.110
Why?
Calcinosis
1
2016
183
0.110
Why?
Proteome
2
2021
257
0.110
Why?
Serine Endopeptidases
1
2015
184
0.110
Why?
BRCA1 Protein
2
2012
71
0.110
Why?
GTP Phosphohydrolases
1
2015
150
0.110
Why?
Communication
1
2018
521
0.110
Why?
Mastectomy, Segmental
2
1994
29
0.110
Why?
Neoplastic Cells, Circulating
1
2015
74
0.110
Why?
Integrin beta1
2
2011
56
0.110
Why?
Securin
1
2014
3
0.110
Why?
Diabetes Mellitus, Experimental
1
2015
139
0.110
Why?
MAP Kinase Kinase Kinase 3
1
2014
9
0.110
Why?
Research Report
1
2014
77
0.110
Why?
Polymorphism, Genetic
1
2017
820
0.110
Why?
Veratrum Alkaloids
2
2017
12
0.110
Why?
Mitotic Index
2
1999
18
0.110
Why?
Neuroepithelial Cells
1
2013
9
0.110
Why?
Tissue Distribution
4
2025
393
0.110
Why?
Nuclear Receptor Co-Repressor 2
2
2012
38
0.110
Why?
Oncogenes
2
2013
173
0.110
Why?
Lung Diseases, Obstructive
1
1993
33
0.110
Why?
DNA-Binding Proteins
5
2019
2071
0.110
Why?
Receptor, IGF Type 1
2
2011
94
0.110
Why?
PPAR gamma
1
2014
84
0.110
Why?
Semaphorins
1
2013
30
0.110
Why?
Receptors, Retinoic Acid
3
2002
97
0.110
Why?
Decision Making
3
2018
671
0.110
Why?
Insulin Resistance
2
2016
645
0.110
Why?
Ultrasonography, Mammary
1
2013
28
0.110
Why?
Thiazolidinediones
1
2014
83
0.110
Why?
Pregnancy Complications, Neoplastic
1
2013
63
0.100
Why?
Patient Selection
2
2015
703
0.100
Why?
Morbidity
2
2000
248
0.100
Why?
Radiology Information Systems
1
2013
23
0.100
Why?
Somatomedins
3
1999
37
0.100
Why?
Cell Adhesion
6
2017
348
0.100
Why?
Hyperglycemia
1
2015
228
0.100
Why?
Cognition
1
2018
734
0.100
Why?
Comprehension
1
2013
78
0.100
Why?
Analysis of Variance
8
2009
1020
0.100
Why?
Genotype
3
2017
2594
0.100
Why?
Histone-Lysine N-Methyltransferase
1
2014
163
0.100
Why?
Sirolimus
1
2014
227
0.100
Why?
Green Fluorescent Proteins
2
2014
389
0.100
Why?
Growth Inhibitors
2
2003
37
0.100
Why?
MicroRNAs
3
2015
868
0.100
Why?
Mental Recall
1
2013
142
0.100
Why?
Cell Differentiation
5
2018
1931
0.100
Why?
Carnitine Acyltransferases
1
2012
6
0.100
Why?
Gene Rearrangement
1
2014
324
0.100
Why?
Insulin Receptor Substrate Proteins
3
2009
81
0.100
Why?
Mammaplasty
1
2013
53
0.100
Why?
Child
14
2024
24766
0.100
Why?
Risk
3
2011
769
0.100
Why?
LIM Domain Proteins
1
2012
62
0.100
Why?
Gene Expression Regulation, Developmental
3
2014
1014
0.100
Why?
Cytokines
3
2013
1306
0.100
Why?
Osteosarcoma
1
2015
255
0.100
Why?
Genes, ras
3
2015
98
0.100
Why?
Research
1
2014
265
0.100
Why?
Doxycycline
2
2014
117
0.100
Why?
Cross-Over Studies
2
2012
320
0.090
Why?
Macrophages
2
2015
642
0.090
Why?
Ubiquitin-Activating Enzymes
1
2011
23
0.090
Why?
Flow Cytometry
7
2014
803
0.090
Why?
Heterozygote
2
2011
674
0.090
Why?
Thoracic Surgery
1
1993
160
0.090
Why?
Phosphoproteins
3
1999
423
0.090
Why?
Costs and Cost Analysis
2
2011
163
0.090
Why?
Oncogene Proteins
2
2010
143
0.090
Why?
Sesquiterpenes
3
2000
25
0.090
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2018
794
0.090
Why?
Neurogenesis
1
2013
204
0.090
Why?
Biometry
1
1992
136
0.090
Why?
Membrane Proteins
4
2013
1551
0.090
Why?
DNA
2
2016
1621
0.090
Why?
Learning Curve
1
2011
53
0.090
Why?
Guanine Nucleotide Dissociation Inhibitors
1
2011
11
0.090
Why?
Papillomaviridae
2
2023
144
0.090
Why?
Muscular Diseases
1
2012
109
0.090
Why?
Immunoenzyme Techniques
5
2010
257
0.090
Why?
Cadherins
1
2012
174
0.090
Why?
Genes, Dominant
3
2006
246
0.090
Why?
Interleukin-17
1
2012
122
0.090
Why?
Small Molecule Libraries
1
2012
130
0.090
Why?
Mice, Inbred BALB C
8
2010
1006
0.090
Why?
Single-Blind Method
1
2011
240
0.090
Why?
Th17 Cells
1
2012
91
0.090
Why?
Immunoblotting
6
2011
309
0.090
Why?
Endometrial Neoplasms
1
1992
99
0.090
Why?
Nanoshells
1
2010
13
0.090
Why?
Calcium
1
2016
1111
0.090
Why?
Deoxycytidine
3
2014
80
0.090
Why?
Obesity
2
2020
2276
0.090
Why?
Tumor Necrosis Factor-alpha
3
2015
683
0.090
Why?
N-Acetylneuraminic Acid
1
1990
27
0.090
Why?
Antigens, Viral, Tumor
1
2010
47
0.090
Why?
Polyomavirus
1
2010
32
0.090
Why?
Alzheimer Disease
1
2018
808
0.090
Why?
Radiation Tolerance
1
2010
49
0.090
Why?
Gold
1
2010
48
0.090
Why?
Retinoid X Receptors
3
2005
31
0.090
Why?
Proto-Oncogene Proteins c-myc
1
2011
212
0.090
Why?
Metabolome
1
2013
295
0.080
Why?
Hyperthermia, Induced
1
2010
56
0.080
Why?
Drug Delivery Systems
2
2009
205
0.080
Why?
Carcinoma, Renal Cell
2
2010
240
0.080
Why?
Neoplasms, Plasma Cell
1
2009
3
0.080
Why?
Lymphoma, Large-Cell, Immunoblastic
1
2009
5
0.080
Why?
Peptide Fragments
4
2008
783
0.080
Why?
Genetic Therapy
2
2025
691
0.080
Why?
Transcriptional Activation
5
2016
483
0.080
Why?
Medicine
1
2011
102
0.080
Why?
Incidence
8
2009
3170
0.080
Why?
Child, Preschool
9
2024
14221
0.080
Why?
Hot Flashes
1
2009
7
0.080
Why?
RNA, Neoplasm
5
2009
138
0.080
Why?
Premenopause
2
2001
31
0.080
Why?
Plasmids
3
2011
514
0.080
Why?
Physicians
2
2018
603
0.080
Why?
p38 Mitogen-Activated Protein Kinases
1
2009
126
0.080
Why?
Cell Cycle Proteins
4
2014
654
0.080
Why?
Mesoderm
1
2009
108
0.080
Why?
Microdissection
1
2009
12
0.080
Why?
Nuclear Matrix-Associated Proteins
1
2009
19
0.080
Why?
Private Sector
1
2009
24
0.080
Why?
Hedgehog Proteins
2
2008
258
0.080
Why?
Matrix Attachment Region Binding Proteins
1
2009
19
0.080
Why?
Sertraline
1
2009
44
0.080
Why?
Drainage
1
2010
260
0.080
Why?
DNA, Complementary
2
2000
465
0.080
Why?
Marketing of Health Services
1
2009
25
0.080
Why?
Neoplasm, Residual
1
2009
122
0.080
Why?
Access to Information
1
2009
41
0.080
Why?
Age Factors
6
2013
2835
0.080
Why?
Medroxyprogesterone
1
1988
8
0.080
Why?
Early Detection of Cancer
2
2023
367
0.080
Why?
Lymphoma, Large B-Cell, Diffuse
2
2009
140
0.080
Why?
Shock, Hemorrhagic
1
2009
56
0.070
Why?
Lung
3
2014
1508
0.070
Why?
Education, Medical, Graduate
1
2013
525
0.070
Why?
Lasers
1
2009
114
0.070
Why?
Registries
3
1999
1454
0.070
Why?
Autistic Disorder
1
2011
351
0.070
Why?
Decision Making, Computer-Assisted
2
2002
19
0.070
Why?
Kidney Neoplasms
2
2010
440
0.070
Why?
Nicotinic Acids
1
2007
7
0.070
Why?
Phenotype
8
2014
4323
0.070
Why?
Tissue Adhesives
1
2008
37
0.070
Why?
Triazoles
3
2014
140
0.070
Why?
Environment, Controlled
1
2007
8
0.070
Why?
Enzyme Activation
4
2011
631
0.070
Why?
Fluorophotometry
1
2007
30
0.070
Why?
Insulin-Like Growth Factor Binding Proteins
3
1997
32
0.070
Why?
Genetic Heterogeneity
2
2006
127
0.070
Why?
Comparative Genomic Hybridization
1
2009
574
0.070
Why?
Drug Screening Assays, Antitumor
7
2000
99
0.070
Why?
Combined Modality Therapy
5
2014
1251
0.070
Why?
Case-Control Studies
5
2017
3341
0.070
Why?
Myelopoiesis
1
2007
13
0.070
Why?
Gene Expression Regulation, Bacterial
2
2006
169
0.070
Why?
Brain Mapping
1
2010
401
0.070
Why?
Patient Acceptance of Health Care
2
2023
431
0.070
Why?
Fixatives
1
2007
14
0.070
Why?
Linear Models
3
2013
694
0.070
Why?
Nerve Tissue Proteins
1
2013
1135
0.070
Why?
Fatty Acids
3
2016
347
0.070
Why?
Fibrocystic Breast Disease
1
2007
5
0.070
Why?
Paraffin Embedding
1
2007
36
0.070
Why?
Cohort Studies
5
2008
4874
0.070
Why?
Formaldehyde
1
2007
37
0.070
Why?
DNA Replication
3
2019
352
0.070
Why?
Phenylurea Compounds
2
2015
53
0.070
Why?
Tissue Fixation
1
2007
37
0.070
Why?
Counseling
1
2009
223
0.070
Why?
Bacterial Capsules
2
2004
40
0.070
Why?
Drug Administration Schedule
6
2013
730
0.070
Why?
Sulfonamides
1
2009
270
0.070
Why?
Myeloid Cells
1
2007
104
0.070
Why?
Smoothened Receptor
3
2015
34
0.070
Why?
Shock
1
2008
91
0.070
Why?
Receptors, Interleukin
1
2006
34
0.070
Why?
Cells, Cultured
5
2018
3040
0.070
Why?
Loss of Heterozygosity
2
2014
132
0.070
Why?
src-Family Kinases
2
2011
93
0.070
Why?
Genetic Predisposition to Disease
5
2024
3203
0.070
Why?
Insulin-Like Growth Factor Binding Protein 3
2
1997
55
0.070
Why?
Nucleic Acid Hybridization
3
2005
394
0.060
Why?
In Vitro Techniques
5
2021
973
0.060
Why?
Mass Screening
2
2023
785
0.060
Why?
Genetic Markers
2
2005
611
0.060
Why?
Granulocyte Colony-Stimulating Factor
2
2022
91
0.060
Why?
Risk Assessment
4
2011
3461
0.060
Why?
Membrane Glycoproteins
2
2003
414
0.060
Why?
Polymerase Chain Reaction
8
2009
1597
0.060
Why?
Sp1 Transcription Factor
2
2004
44
0.060
Why?
Virus Latency
2
2015
60
0.060
Why?
Contrast Media
1
2010
484
0.060
Why?
Clinical Trials, Phase II as Topic
2
2020
73
0.060
Why?
Models, Biological
5
2014
1469
0.060
Why?
Cathepsin D
2
1997
17
0.060
Why?
Enterococcus faecalis
1
2006
44
0.060
Why?
Patient Education as Topic
1
2009
443
0.060
Why?
Fluorescent Antibody Technique
4
2010
423
0.060
Why?
Proto-Oncogene Proteins c-fos
1
2005
59
0.060
Why?
Drug Resistance
6
1998
257
0.060
Why?
Wounds and Injuries
1
2009
375
0.060
Why?
Hyperplasia
4
2015
198
0.060
Why?
Cyclin D1
3
2011
115
0.060
Why?
In Situ Hybridization, Fluorescence
2
2019
779
0.060
Why?
Raloxifene Hydrochloride
1
2004
16
0.060
Why?
Magnetic Resonance Imaging
2
2022
3622
0.060
Why?
Neutrophils
1
2007
383
0.060
Why?
Probability
4
2002
321
0.060
Why?
Biological Specimen Banks
1
2005
51
0.060
Why?
Florida
4
1992
79
0.060
Why?
Serogroup
1
2025
60
0.060
Why?
Polymorphism, Single Nucleotide
2
2017
2689
0.060
Why?
Pediatrics
1
2014
1161
0.060
Why?
Clinical Competence
1
2011
1008
0.060
Why?
Gambia
1
2024
28
0.060
Why?
Barrett Esophagus
1
2009
348
0.060
Why?
Proto-Oncogene Proteins c-akt
3
2014
495
0.060
Why?
Apoptosis Regulatory Proteins
2
2021
156
0.060
Why?
Drug Synergism
4
2016
228
0.060
Why?
DNA Probes
1
2004
124
0.060
Why?
Smartphone
1
2024
39
0.060
Why?
Cytological Techniques
2
1995
17
0.060
Why?
Sample Size
1
2004
88
0.050
Why?
Diet, High-Fat
2
2016
212
0.050
Why?
Coculture Techniques
2
2015
232
0.050
Why?
Plasma
2
2016
99
0.050
Why?
Transduction, Genetic
1
2025
290
0.050
Why?
Epilepsy
1
2011
875
0.050
Why?
Albumins
1
2024
95
0.050
Why?
Genes, Neoplasm
3
2011
82
0.050
Why?
Antigens, Surface
2
2015
118
0.050
Why?
Topoisomerase I Inhibitors
2
1994
16
0.050
Why?
Gene Silencing
3
2011
243
0.050
Why?
Vaginal Smears
1
2023
48
0.050
Why?
Protein-Tyrosine Kinases
1
2024
215
0.050
Why?
Menopause
3
2005
75
0.050
Why?
Neoplasms, Second Primary
1
2005
143
0.050
Why?
Pyrimidines
2
2017
389
0.050
Why?
Homeodomain Proteins
1
2006
560
0.050
Why?
Obstetric Labor Complications
1
2024
93
0.050
Why?
NFI Transcription Factors
1
2023
51
0.050
Why?
Germ Cells
1
2024
198
0.050
Why?
Mitogen-Activated Protein Kinase Kinases
1
2023
91
0.050
Why?
Muscle, Skeletal
3
2016
980
0.050
Why?
Arsenicals
1
2003
13
0.050
Why?
United States
9
2021
10990
0.050
Why?
Oxides
1
2003
14
0.050
Why?
RNA Interference
2
2017
512
0.050
Why?
Membrane Transport Proteins
2
2019
175
0.050
Why?
Gene Knockdown Techniques
2
2014
375
0.050
Why?
Interferons
1
2023
128
0.050
Why?
Mobile Applications
1
2024
93
0.050
Why?
Bacillus anthracis
1
2003
40
0.050
Why?
CTLA-4 Antigen
1
2023
62
0.050
Why?
Mastectomy, Radical
3
2000
8
0.050
Why?
Protein Isoforms
3
2011
403
0.050
Why?
Regression Analysis
5
2013
784
0.050
Why?
Proteins
1
2008
1043
0.050
Why?
Laparotomy
2
2008
136
0.050
Why?
Lung Diseases
2
1996
390
0.050
Why?
Vidarabine
1
2022
77
0.050
Why?
Cytarabine
1
2022
97
0.050
Why?
Sensitivity and Specificity
5
2010
2068
0.050
Why?
Fracture Fixation, Internal
1
2002
76
0.050
Why?
Caspases
1
2003
163
0.050
Why?
Cystoscopy
1
2022
44
0.050
Why?
Confidentiality
2
2013
103
0.050
Why?
Self Care
1
2023
215
0.050
Why?
Hysterectomy
2
1995
187
0.050
Why?
B7-H1 Antigen
1
2023
122
0.050
Why?
Mutagenesis
2
2019
343
0.050
Why?
Amino Acids
2
2016
669
0.050
Why?
Infant
6
2024
12681
0.050
Why?
Pregnancy
4
2024
7257
0.050
Why?
Hip Fractures
1
2002
68
0.050
Why?
Infusions, Intravenous
5
2005
554
0.050
Why?
Nitriles
2
2013
146
0.050
Why?
Colony-Forming Units Assay
2
2014
70
0.050
Why?
Logistic Models
3
2010
1812
0.050
Why?
Prenatal Care
1
2024
349
0.050
Why?
Rats
5
2009
3763
0.050
Why?
Hyaluronan Receptors
2
2013
66
0.050
Why?
Oxidative Stress
2
2010
828
0.040
Why?
ROC Curve
2
2015
577
0.040
Why?
Multiple Myeloma
2
2003
152
0.040
Why?
Uterus
1
2005
568
0.040
Why?
Dihydrotestosterone
1
2020
67
0.040
Why?
Muscle Proteins
1
2003
416
0.040
Why?
Enzyme Inhibitors
1
2003
592
0.040
Why?
Protein Biosynthesis
2
2016
666
0.040
Why?
Chi-Square Distribution
3
2005
588
0.040
Why?
Rural Population
2
2000
259
0.040
Why?
Biopsy
3
2009
1257
0.040
Why?
In Situ Hybridization
2
2005
472
0.040
Why?
Ubiquitin
1
2021
143
0.040
Why?
Matrix Metalloproteinase 9
1
2001
140
0.040
Why?
DNA Primers
4
2007
659
0.040
Why?
Spirometry
2
1997
73
0.040
Why?
Tretinoin
1
2000
114
0.040
Why?
Cell Separation
2
2014
229
0.040
Why?
Tacrolimus
1
2000
99
0.040
Why?
Cryptosporidium parvum
1
2000
27
0.040
Why?
Cryptosporidiosis
1
2000
41
0.040
Why?
Glucose
2
2016
881
0.040
Why?
Wnt Signaling Pathway
1
2021
195
0.040
Why?
Antibodies, Protozoan
1
2000
76
0.040
Why?
Co-Repressor Proteins
1
2020
37
0.040
Why?
Cholecystectomy, Laparoscopic
1
2000
44
0.040
Why?
Chromosome Aberrations
2
2009
616
0.040
Why?
Gene Expression Regulation, Enzymologic
1
2001
255
0.040
Why?
Carcinogens
3
2008
148
0.040
Why?
Clinical Trials, Phase III as Topic
1
2020
69
0.040
Why?
Radiography
1
2022
805
0.040
Why?
Hepatitis Antibodies
1
1999
5
0.040
Why?
Liver
3
2016
1758
0.040
Why?
Knowledge Bases
1
2019
36
0.040
Why?
Amino Acid Motifs
1
2020
194
0.040
Why?
Pilot Projects
3
1999
1413
0.040
Why?
TNF-Related Apoptosis-Inducing Ligand
2
2014
23
0.040
Why?
Proto-Oncogene Proteins
2
2014
566
0.040
Why?
DNA Topoisomerases, Type II
1
1999
23
0.040
Why?
Hepatitis A
1
1999
32
0.040
Why?
Chromosomes, Human, Pair 18
1
1999
62
0.040
Why?
Open Reading Frames
2
2014
214
0.040
Why?
Medically Uninsured
1
2020
74
0.040
Why?
Adaptor Proteins, Signal Transducing
2
2014
569
0.040
Why?
Pregnancy Complications
1
2024
517
0.040
Why?
Molecular Probe Techniques
1
1999
23
0.040
Why?
G2 Phase
2
2003
43
0.040
Why?
ras Proteins
1
2020
137
0.040
Why?
CD24 Antigen
2
2009
31
0.040
Why?
Folic Acid Antagonists
1
1999
16
0.040
Why?
Chromosomes, Human, Pair 14
1
1999
102
0.040
Why?
Benzofurans
1
1999
24
0.040
Why?
Antigens, Neoplasm
3
2005
384
0.040
Why?
Anthropometry
1
1999
198
0.040
Why?
HEK293 Cells
1
2021
746
0.040
Why?
Glutamates
1
1999
68
0.040
Why?
JNK Mitogen-Activated Protein Kinases
3
2005
90
0.040
Why?
Chromosomal Instability
1
2019
57
0.040
Why?
Guanine
1
1999
61
0.040
Why?
Neovascularization, Pathologic
2
2010
239
0.040
Why?
Mechanistic Target of Rapamycin Complex 1
1
2019
167
0.040
Why?
Candidiasis, Oral
1
1998
2
0.040
Why?
HSP70 Heat-Shock Proteins
2
1996
70
0.040
Why?
MAP Kinase Signaling System
2
2011
315
0.040
Why?
Pimozide
1
2018
7
0.040
Why?
Remission Induction
1
2019
297
0.040
Why?
Socioeconomic Factors
2
2020
867
0.040
Why?
Oropharynx
1
1998
34
0.040
Why?
Mammals
1
2019
257
0.040
Why?
Molecular Sequence Data
6
2004
3901
0.040
Why?
Recurrence
4
2012
1400
0.040
Why?
Fluconazole
1
1998
48
0.040
Why?
Hyperprolactinemia
1
2018
22
0.040
Why?
Phthalimides
1
1998
2
0.040
Why?
Professional-Family Relations
1
2018
94
0.040
Why?
Solubility
1
2018
141
0.040
Why?
Length of Stay
2
2011
1325
0.040
Why?
Rats, Inbred WF
3
2002
21
0.040
Why?
Methylnitrosourea
3
2002
18
0.040
Why?
Academic Medical Centers
1
2020
311
0.040
Why?
Colonic Neoplasms
2
1999
250
0.040
Why?
NIH 3T3 Cells
2
2010
92
0.040
Why?
Cross-Sectional Studies
2
2024
3457
0.040
Why?
Cyclin-Dependent Kinase Inhibitor p21
2
2014
84
0.040
Why?
Epigenesis, Genetic
1
2022
718
0.040
Why?
Chorioallantoic Membrane
1
2017
12
0.040
Why?
Breast Neoplasms, Male
2
2011
15
0.040
Why?
Plaque, Amyloid
1
2018
65
0.040
Why?
Photoreceptor Cells
1
1998
91
0.040
Why?
Risperidone
1
2018
59
0.040
Why?
Immunization, Passive
1
2018
121
0.040
Why?
Patients
1
2018
121
0.040
Why?
AIDS-Related Opportunistic Infections
1
1998
135
0.040
Why?
Androstadienes
1
2017
50
0.040
Why?
Chick Embryo
1
2017
131
0.030
Why?
Receptor Protein-Tyrosine Kinases
1
2018
131
0.030
Why?
Genes, Reporter
2
2014
382
0.030
Why?
Alleles
2
2017
1625
0.030
Why?
Virus Activation
1
1998
84
0.030
Why?
Mitosis
2
2011
189
0.030
Why?
NF-kappa B
2
2013
469
0.030
Why?
Genomic Instability
1
2019
232
0.030
Why?
Pharmacogenomic Variants
1
2017
35
0.030
Why?
Hydroxyurea
1
1998
83
0.030
Why?
Early Termination of Clinical Trials
1
2017
16
0.030
Why?
Bridged-Ring Compounds
1
2017
17
0.030
Why?
Genes, cdc
1
1997
25
0.030
Why?
Cyclooxygenase Inhibitors
2
2009
55
0.030
Why?
Flutamide
1
1997
27
0.030
Why?
Retinal Degeneration
1
1998
95
0.030
Why?
Cytosol
1
1997
163
0.030
Why?
Cyclins
1
1997
104
0.030
Why?
Telomerase
1
1997
169
0.030
Why?
Protein Binding
2
2017
1749
0.030
Why?
Salivary Gland Neoplasms
1
1997
55
0.030
Why?
Radiation-Sensitizing Agents
2
1993
25
0.030
Why?
Administration, Oral
3
2000
700
0.030
Why?
Postmenopause
1
1997
129
0.030
Why?
Ovariectomy
2
2008
181
0.030
Why?
Congenital Abnormalities
1
1999
259
0.030
Why?
Immunosuppressive Agents
1
2000
653
0.030
Why?
Cell Line
4
2007
2734
0.030
Why?
Chromosomal Proteins, Non-Histone
1
1997
203
0.030
Why?
Chromosome Deletion
1
1999
656
0.030
Why?
Temporomandibular Joint Dysfunction Syndrome
1
1996
2
0.030
Why?
Lysosomes
1
2018
245
0.030
Why?
Statistics, Nonparametric
2
2013
435
0.030
Why?
Effect Modifier, Epidemiologic
1
1996
10
0.030
Why?
Malocclusion, Angle Class II
1
1996
3
0.030
Why?
Maximum Tolerated Dose
1
2016
167
0.030
Why?
Tumor Virus Infections
1
1997
134
0.030
Why?
Receptor, Insulin
2
2010
69
0.030
Why?
Cyclophosphamide
2
2010
414
0.030
Why?
Telomere
1
1997
219
0.030
Why?
Vitamin D
1
2017
167
0.030
Why?
Hospital Costs
1
1997
180
0.030
Why?
Etoposide
2
2014
117
0.030
Why?
Antifungal Agents
1
1998
294
0.030
Why?
Drosophila
2
2015
792
0.030
Why?
Polyethylene Glycols
1
1997
244
0.030
Why?
Cyclin-Dependent Kinases
1
2016
89
0.030
Why?
Dietary Supplements
1
2019
474
0.030
Why?
Primary Prevention
1
2017
172
0.030
Why?
Behavior, Animal
1
2018
498
0.030
Why?
Mammography
1
2016
116
0.030
Why?
Bias
1
1996
136
0.030
Why?
Axons
1
2018
375
0.030
Why?
Receptors, Calcitonin
1
1995
21
0.030
Why?
Cell Self Renewal
1
2015
45
0.030
Why?
Transforming Growth Factor alpha
1
1994
27
0.030
Why?
Endoplasmic Reticulum
1
2016
218
0.030
Why?
Capecitabine
1
2014
17
0.030
Why?
Calcitonin
1
1995
32
0.030
Why?
Preoperative Care
1
1997
358
0.030
Why?
Retinoids
2
2006
32
0.030
Why?
Medication Adherence
1
2019
401
0.030
Why?
Physician-Patient Relations
1
2018
435
0.030
Why?
Base Sequence
5
2002
3118
0.030
Why?
Retina
1
1998
458
0.030
Why?
Herpesvirus 4, Human
1
1998
674
0.030
Why?
Organoids
1
2017
274
0.030
Why?
Osteoclasts
1
1995
56
0.030
Why?
Iodine Radioisotopes
1
1994
75
0.030
Why?
Spheroids, Cellular
1
2014
60
0.030
Why?
Fluorescence
1
2014
96
0.030
Why?
Insulin-Secreting Cells
1
2016
148
0.030
Why?
Crosses, Genetic
2
2009
164
0.030
Why?
Antipsychotic Agents
1
2018
374
0.030
Why?
Retroviridae
1
2015
196
0.030
Why?
Drug Therapy, Combination
1
2018
1168
0.030
Why?
Synapses
1
2018
456
0.030
Why?
Salvage Therapy
1
1996
189
0.030
Why?
Lentivirus
1
2014
82
0.030
Why?
Topotecan
3
2000
48
0.030
Why?
Collagen
1
2015
319
0.030
Why?
Virion
1
2015
148
0.030
Why?
Alternative Splicing
1
1996
357
0.030
Why?
Random Allocation
2
2011
442
0.030
Why?
Allografts
1
2015
177
0.030
Why?
Heart Diseases
2
1996
503
0.030
Why?
Immunophenotyping
1
2015
327
0.030
Why?
Gene Regulatory Networks
1
2016
369
0.030
Why?
Mice, Mutant Strains
2
2009
387
0.030
Why?
Inflammation
2
2015
1462
0.030
Why?
Hospital Bed Capacity, 500 and over
1
1993
14
0.030
Why?
Hospitals, Military
1
1993
10
0.030
Why?
Alveolar Epithelial Cells
1
2014
35
0.030
Why?
Azepines
1
2014
64
0.030
Why?
Chromatids
1
2014
41
0.030
Why?
Quality of Life
2
2017
1954
0.030
Why?
Proteolysis
1
2014
171
0.030
Why?
Seminal Vesicles
1
2013
55
0.030
Why?
Drug Evaluation, Preclinical
1
2014
154
0.030
Why?
Conjunctiva
1
1995
197
0.030
Why?
Mexico
3
2000
181
0.030
Why?
Escherichia coli
1
2019
974
0.030
Why?
Hospitals, Teaching
1
1993
105
0.030
Why?
Blood Proteins
1
1993
124
0.030
Why?
Epidemiologic Factors
1
2013
8
0.030
Why?
Integrin alpha6
1
2013
5
0.030
Why?
Epigenomics
1
2014
181
0.030
Why?
Epithelium
2
2009
362
0.030
Why?
Pyrroles
1
2014
184
0.030
Why?
Hospitals, Public
1
2013
41
0.030
Why?
Enhancer Elements, Genetic
1
2014
298
0.030
Why?
Liver Cirrhosis
1
2000
877
0.030
Why?
AC133 Antigen
1
2013
36
0.030
Why?
Binding Sites
1
2016
1305
0.030
Why?
Personal Satisfaction
1
2013
103
0.030
Why?
Intercellular Signaling Peptides and Proteins
1
2014
285
0.030
Why?
Ploidies
1
2012
37
0.030
Why?
Axilla
3
1999
39
0.030
Why?
Genome-Wide Association Study
2
2011
1725
0.030
Why?
Cell Nucleolus
1
2012
49
0.020
Why?
Rats, Sprague-Dawley
2
2009
1261
0.020
Why?
Gene Knockout Techniques
1
2013
130
0.020
Why?
Peritoneal Cavity
1
1992
19
0.020
Why?
Ketosis
1
2012
15
0.020
Why?
Phospholipid Ethers
1
1992
7
0.020
Why?
Protein Kinases
2
2008
332
0.020
Why?
Odds Ratio
2
2011
1266
0.020
Why?
Mammary Glands, Human
1
2013
80
0.020
Why?
Interviews as Topic
1
2013
380
0.020
Why?
Diphenhydramine
1
1992
11
0.020
Why?
Droperidol
1
1992
3
0.020
Why?
Alkaloids
1
1992
34
0.020
Why?
9,10-Dimethyl-1,2-benzanthracene
2
2002
54
0.020
Why?
Metoclopramide
1
1992
9
0.020
Why?
Lorazepam
1
1992
12
0.020
Why?
Antigens, CD1
1
2012
22
0.020
Why?
Point Mutation
1
1993
350
0.020
Why?
Receptor, ErbB-3
1
2011
16
0.020
Why?
Nuclear Receptor Coactivator 1
1
2013
240
0.020
Why?
Menstrual Cycle
1
1992
34
0.020
Why?
Insurance Coverage
1
2013
121
0.020
Why?
Tetradecanoylphorbol Acetate
2
2004
66
0.020
Why?
Hyperammonemia
1
2012
63
0.020
Why?
Antiemetics
1
1992
22
0.020
Why?
Spindle Apparatus
1
2011
49
0.020
Why?
Sequence Analysis, RNA
1
2014
386
0.020
Why?
Focal Adhesion Kinase 1
1
2011
25
0.020
Why?
Interleukin-1
1
1992
142
0.020
Why?
Image Processing, Computer-Assisted
2
2010
589
0.020
Why?
Tumor Burden
1
2012
236
0.020
Why?
Oncogene Protein v-akt
1
2011
31
0.020
Why?
Sumoylation
1
2011
37
0.020
Why?
Pancreatic Diseases
1
2011
38
0.020
Why?
Cefoxitin
1
1991
5
0.020
Why?
Avian Leukosis Virus
1
2011
14
0.020
Why?
Vulnerable Populations
1
2013
138
0.020
Why?
Blood Cells
2
1988
51
0.020
Why?
Nuclear Receptor Coactivator 2
1
2013
203
0.020
Why?
rho-Specific Guanine Nucleotide Dissociation Inhibitors
1
2011
8
0.020
Why?
Antigen-Presenting Cells
1
2012
118
0.020
Why?
Gene Dosage
2
2008
447
0.020
Why?
rho Guanine Nucleotide Dissociation Inhibitor alpha
1
2011
10
0.020
Why?
Hypoglycemic Agents
1
2015
448
0.020
Why?
Chromatin
1
2014
578
0.020
Why?
Elective Surgical Procedures
3
1997
161
0.020
Why?
Dendritic Cells
1
2014
417
0.020
Why?
Oxidation-Reduction
1
2012
447
0.020
Why?
Gene Order
1
2011
80
0.020
Why?
Gene Deletion
2
2006
797
0.020
Why?
CpG Islands
1
2012
335
0.020
Why?
Insulin
1
2016
1207
0.020
Why?
Cell-Matrix Junctions
1
2010
9
0.020
Why?
Pedigree
2
2006
1615
0.020
Why?
Radiation, Ionizing
1
2010
42
0.020
Why?
Antigens, CD
1
2013
431
0.020
Why?
cdc42 GTP-Binding Protein
1
2010
31
0.020
Why?
Antigens, Tumor-Associated, Carbohydrate
1
1990
12
0.020
Why?
Amylases
1
2010
26
0.020
Why?
Sialic Acids
1
1990
20
0.020
Why?
Blood Loss, Surgical
1
2011
152
0.020
Why?
Epirubicin
1
2010
5
0.020
Why?
Immunoprecipitation
1
2011
198
0.020
Why?
Recombinant Proteins
3
2005
1399
0.020
Why?
Educational Measurement
1
2013
324
0.020
Why?
Polyribosomes
1
2010
25
0.020
Why?
rhoA GTP-Binding Protein
1
2010
46
0.020
Why?
Hypoglycemia
1
2012
193
0.020
Why?
Glycoproteins
1
2013
362
0.020
Why?
rho GTP-Binding Proteins
1
2011
68
0.020
Why?
rac1 GTP-Binding Protein
1
2010
67
0.020
Why?
Benzimidazoles
1
2011
134
0.020
Why?
Pyridones
1
2011
119
0.020
Why?
Dexamethasone
1
1992
276
0.020
Why?
Hormones
2
1988
189
0.020
Why?
Leukemia
1
1993
368
0.020
Why?
RNA-Binding Proteins
1
2014
579
0.020
Why?
Antibodies
1
2011
370
0.020
Why?
Cell Growth Processes
1
2009
67
0.020
Why?
Ribosomal Protein S6 Kinases
1
2009
50
0.020
Why?
Prevalence
3
2002
2484
0.020
Why?
Claudin-1
1
2009
20
0.020
Why?
Quality Control
1
1990
123
0.020
Why?
Lymphoma, AIDS-Related
1
2009
39
0.020
Why?
Neoplasms, Multiple Primary
1
1990
70
0.020
Why?
Cytoplasm
1
2010
296
0.020
Why?
Protein Phosphatase 2C
1
2009
55
0.020
Why?
Area Under Curve
1
2010
324
0.020
Why?
Thrombospondin 1
1
2009
23
0.020
Why?
DNA Breaks, Double-Stranded
1
2010
134
0.020
Why?
Secondary Prevention
1
2011
215
0.020
Why?
Blood Transfusion
1
2011
314
0.020
Why?
Radiotherapy Dosage
1
1990
188
0.020
Why?
Interferon-gamma
1
2012
511
0.020
Why?
Quality Indicators, Health Care
1
2011
221
0.020
Why?
Lipid Metabolism
1
2012
356
0.020
Why?
Peptides
1
2013
820
0.020
Why?
Epiregulin
1
2009
3
0.020
Why?
Celecoxib
1
2009
30
0.020
Why?
G-Quadruplexes
1
2009
10
0.020
Why?
Microfilament Proteins
2
2003
280
0.020
Why?
Canada
1
1990
291
0.020
Why?
Lymph Node Excision
1
1990
164
0.020
Why?
Vascular Endothelial Growth Factor A
1
2011
413
0.020
Why?
Phosphoprotein Phosphatases
1
2009
117
0.020
Why?
Protein Processing, Post-Translational
1
2011
362
0.020
Why?
Oligodeoxyribonucleotides
1
2009
137
0.020
Why?
beta Catenin
1
2010
216
0.020
Why?
Computational Biology
1
2014
838
0.020
Why?
Image Enhancement
1
2010
163
0.020
Why?
Sampling Studies
1
1988
76
0.020
Why?
Hematopoietic System
1
1988
6
0.020
Why?
Kinetics
2
2003
1325
0.020
Why?
Parity
1
2008
78
0.020
Why?
Medroxyprogesterone Acetate
1
1988
16
0.020
Why?
Histiocytes
1
1988
24
0.020
Why?
Nucleotidyltransferases
1
2008
43
0.020
Why?
Cell Transplantation
1
2008
45
0.020
Why?
Epidermal Growth Factor
1
2009
122
0.020
Why?
Pharmacogenetics
1
2009
187
0.020
Why?
Imidazoles
1
2009
210
0.020
Why?
Binding, Competitive
1
2008
193
0.020
Why?
Bacterial Infections
1
1991
304
0.020
Why?
Pancreaticojejunostomy
1
2008
6
0.020
Why?
Principal Component Analysis
1
2009
147
0.020
Why?
Genetic Variation
1
1995
1512
0.020
Why?
Pregnancy, Animal
1
2008
75
0.020
Why?
Carcinoma, Non-Small-Cell Lung
2
1992
355
0.020
Why?
Hypovolemia
1
2008
11
0.020
Why?
Pulmonary Alveoli
1
2009
136
0.020
Why?
Interleukin-2
1
1988
244
0.020
Why?
Comorbidity
1
2013
1542
0.020
Why?
Esophagoscopy
1
2009
158
0.020
Why?
Postoperative Care
1
1990
299
0.020
Why?
Unnecessary Procedures
1
2008
56
0.020
Why?
Poly(ADP-ribose) Polymerases
2
2003
63
0.020
Why?
Stomach Neoplasms
1
1994
550
0.020
Why?
Reactive Oxygen Species
1
2010
499
0.020
Why?
Myocardium
1
2013
1029
0.020
Why?
Phagocytosis
1
1988
172
0.020
Why?
Cell Membrane
1
2009
467
0.020
Why?
Patched Receptors
1
2007
35
0.020
Why?
Patched-1 Receptor
1
2007
44
0.020
Why?
Choline Dehydrogenase
1
2006
2
0.020
Why?
Lipids
1
1990
524
0.020
Why?
Receptors, Interleukin-17
1
2006
6
0.020
Why?
Body Mass Index
1
2013
1582
0.020
Why?
Caspase 3
1
2007
135
0.020
Why?
United Kingdom
1
2007
202
0.020
Why?
Stem Cell Transplantation
1
2008
237
0.020
Why?
Dual Specificity Phosphatase 6
1
2006
2
0.020
Why?
Resuscitation
1
2009
253
0.020
Why?
Homozygote
1
2008
549
0.020
Why?
RNA, Bacterial
1
2006
54
0.020
Why?
Metabolism
1
2006
42
0.020
Why?
Embryo, Mammalian
1
2008
456
0.020
Why?
Clone Cells
2
1999
169
0.020
Why?
HIV-1
1
2009
469
0.020
Why?
DNA, Antisense
1
2005
8
0.020
Why?
Aneuploidy
2
1997
141
0.020
Why?
Neuregulin-1
1
2005
13
0.020
Why?
DNA Copy Number Variations
1
2011
975
0.020
Why?
Drug Resistance, Multiple
1
2005
48
0.020
Why?
In Situ Nick-End Labeling
1
2005
127
0.020
Why?
Genes, Homeobox
1
2005
71
0.020
Why?
Dimerization
1
2005
143
0.020
Why?
Retinoic Acid 4-Hydroxylase
1
2005
6
0.020
Why?
Cholesterol
1
2008
544
0.020
Why?
Biofilms
1
2006
86
0.010
Why?
Double-Blind Method
1
2009
1611
0.010
Why?
Amino Acid Sequence
2
2004
2719
0.010
Why?
Drosophila melanogaster
1
2010
789
0.010
Why?
Prostaglandin-Endoperoxide Synthases
1
2005
75
0.010
Why?
Diabetes Mellitus, Type 2
1
2015
1282
0.010
Why?
Enzymes
1
2005
51
0.010
Why?
Cyclooxygenase 2 Inhibitors
1
2005
53
0.010
Why?
E1A-Associated p300 Protein
1
2005
54
0.010
Why?
Ethics, Research
1
2005
53
0.010
Why?
Substrate Specificity
1
2005
292
0.010
Why?
Luciferases
1
2004
132
0.010
Why?
Cyclooxygenase 2
1
2005
146
0.010
Why?
Neovascularization, Physiologic
1
2005
219
0.010
Why?
Cytochrome P-450 Enzyme System
1
2005
135
0.010
Why?
Chromatin Immunoprecipitation
1
2004
240
0.010
Why?
Patient Care Planning
1
2005
122
0.010
Why?
Multicenter Studies as Topic
1
2004
274
0.010
Why?
Multigene Family
1
2004
302
0.010
Why?
Ligands
1
2005
543
0.010
Why?
Integrases
1
2004
161
0.010
Why?
Caspase 8
1
2003
22
0.010
Why?
Cysteine Proteinase Inhibitors
1
2003
41
0.010
Why?
Culture Media, Serum-Free
1
2002
23
0.010
Why?
Acetyltransferases
1
2003
89
0.010
Why?
Chromatography, High Pressure Liquid
2
1994
343
0.010
Why?
Sp3 Transcription Factor
1
2002
7
0.010
Why?
Cloning, Molecular
2
1995
899
0.010
Why?
Biopsy, Needle
1
2003
228
0.010
Why?
Myocytes, Cardiac
1
2008
651
0.010
Why?
Electrophoretic Mobility Shift Assay
1
2002
49
0.010
Why?
Protein Structure, Tertiary
1
2004
765
0.010
Why?
G1 Phase
1
2003
66
0.010
Why?
Laparoscopy
1
2008
495
0.010
Why?
Carbon Dioxide
1
2004
280
0.010
Why?
Caspase 9
1
2003
75
0.010
Why?
Virulence
1
2003
271
0.010
Why?
Growth Substances
1
2002
114
0.010
Why?
Injections, Intralesional
1
2002
48
0.010
Why?
Viral Proteins
1
2004
348
0.010
Why?
Benzoates
1
2002
21
0.010
Why?
Thymidine Kinase
1
2002
95
0.010
Why?
Respiratory Tract Diseases
1
2002
77
0.010
Why?
Severity of Illness Index
1
2010
2933
0.010
Why?
Genetic Carrier Screening
1
2002
69
0.010
Why?
beta-Galactosidase
1
2002
147
0.010
Why?
Reproductive History
1
2001
10
0.010
Why?
Ganciclovir
1
2002
105
0.010
Why?
Histone Acetyltransferases
1
2003
312
0.010
Why?
Medical Records
1
2002
192
0.010
Why?
Bromodeoxyuridine
1
2001
59
0.010
Why?
Proto-Oncogene Proteins c-yes
1
2001
3
0.010
Why?
Mice, Inbred Strains
1
2001
310
0.010
Why?
Liver Neoplasms
2
1988
1334
0.010
Why?
RNA
1
2004
578
0.010
Why?
Chloramphenicol O-Acetyltransferase
1
2000
79
0.010
Why?
Brain
1
2013
3034
0.010
Why?
Pentose Phosphate Pathway
1
2000
43
0.010
Why?
Lipid Peroxidation
1
2000
95
0.010
Why?
Food Deprivation
1
2000
33
0.010
Why?
Inhibitory Concentration 50
1
2000
80
0.010
Why?
Antigens, Polyomavirus Transforming
1
2000
88
0.010
Why?
Blotting, Northern
1
2000
266
0.010
Why?
Glutathione Transferase
1
2000
157
0.010
Why?
Bone Marrow
2
1995
326
0.010
Why?
Superoxide Dismutase
1
2000
180
0.010
Why?
Tomography, X-Ray Computed
1
2008
2106
0.010
Why?
Software
1
2004
698
0.010
Why?
Hepatitis A Antibodies
1
1999
9
0.010
Why?
HSP27 Heat-Shock Proteins
1
1999
7
0.010
Why?
Topoisomerase II Inhibitors
1
1999
15
0.010
Why?
DNA Fragmentation
1
1999
56
0.010
Why?
Receptors, Somatomedin
1
1999
25
0.010
Why?
Adenoviridae
1
2002
602
0.010
Why?
HT29 Cells
1
1999
44
0.010
Why?
Pemetrexed
1
1999
9
0.010
Why?
Sarcoma, Ewing
1
2000
111
0.010
Why?
DNA Mutational Analysis
1
2001
813
0.010
Why?
Carboplatin
1
1999
78
0.010
Why?
Isoenzymes
1
1999
228
0.010
Why?
Calcium-Calmodulin-Dependent Protein Kinases
1
1999
117
0.010
Why?
Urban Population
1
2000
230
0.010
Why?
Histones
1
2002
536
0.010
Why?
Molecular Chaperones
1
1999
169
0.010
Why?
Drug Resistance, Microbial
1
1998
192
0.010
Why?
Anorexia
1
1998
23
0.010
Why?
Hepatitis B
1
1999
163
0.010
Why?
Half-Life
1
1998
157
0.010
Why?
Nuclear Receptor Co-Repressor 1
1
1998
55
0.010
Why?
Radiotherapy, Adjuvant
1
1998
145
0.010
Why?
Butyrates
1
1998
35
0.010
Why?
Nausea
1
1998
85
0.010
Why?
Birth Weight
1
1999
346
0.010
Why?
Energy Intake
1
2000
501
0.010
Why?
Rhabdomyosarcoma
1
2000
193
0.010
Why?
Utilization Review
1
1997
39
0.010
Why?
Intestinal Absorption
1
1998
190
0.010
Why?
Insurance, Health, Reimbursement
1
1997
34
0.010
Why?
Hospitals, University
1
1997
99
0.010
Why?
Hospitals, Urban
1
1997
97
0.010
Why?
Ascites
1
1997
95
0.010
Why?
Antiviral Agents
1
2002
769
0.010
Why?
Chromosome Mapping
1
1999
1089
0.010
Why?
Immunoradiometric Assay
1
1996
3
0.010
Why?
Microscopy, Fluorescence
1
1998
328
0.010
Why?
Graft vs Host Disease
1
2000
505
0.010
Why?
Densitometry
1
1996
24
0.010
Why?
Autoradiography
1
1996
71
0.010
Why?
Staining and Labeling
1
1997
184
0.010
Why?
Loperamide
1
1996
8
0.010
Why?
Neutropenia
1
1998
197
0.010
Why?
Antidiarrheals
1
1996
17
0.010
Why?
Orthodontics, Corrective
1
1996
2
0.010
Why?
Health Expenditures
1
1997
106
0.010
Why?
Mandibular Advancement
1
1996
6
0.010
Why?
Antigens, Viral
1
1998
438
0.010
Why?
Cephalometry
1
1996
34
0.010
Why?
Metaphase
1
1995
33
0.010
Why?
Respiratory Function Tests
1
1996
202
0.010
Why?
Micropore Filters
1
1995
6
0.010
Why?
Range of Motion, Articular
1
1996
74
0.010
Why?
Cellulose
1
1995
26
0.010
Why?
Hepatitis C
1
1999
372
0.010
Why?
Microscopy, Electron, Scanning
1
1995
148
0.010
Why?
Neuroblastoma
1
2000
530
0.010
Why?
Hospitals, Veterans
1
1997
352
0.010
Why?
Metallothionein
1
1994
14
0.010
Why?
Culture Media, Conditioned
1
1994
85
0.010
Why?
Hemoglobins
1
1996
315
0.010
Why?
Calcitriol
1
1995
80
0.010
Why?
Rabbits
1
1995
719
0.010
Why?
Depression, Chemical
1
1994
43
0.010
Why?
Stimulation, Chemical
1
1994
65
0.010
Why?
Isomerism
1
1994
30
0.010
Why?
Diarrhea
1
1996
316
0.010
Why?
Insulin-Like Growth Factor Binding Protein 1
1
1993
20
0.010
Why?
Least-Squares Analysis
1
1993
34
0.010
Why?
Codon
1
1994
99
0.010
Why?
Precipitin Tests
1
1993
156
0.010
Why?
Medicare
1
1997
433
0.010
Why?
Body Weight
1
1998
1004
0.010
Why?
Bone Marrow Cells
1
1995
265
0.010
Why?
Oligonucleotides, Antisense
1
1993
80
0.010
Why?
Genome
1
1995
482
0.010
Why?
Monocytes
1
1995
347
0.010
Why?
Carcinoma, Small Cell
1
1992
51
0.010
Why?
Deamination
1
1992
2
0.010
Why?
Tetrahydrouridine
1
1992
2
0.010
Why?
Hematopoietic Stem Cell Transplantation
1
2000
1105
0.010
Why?
Exons
1
1994
808
0.010
Why?
Pentoxifylline
1
1990
20
0.010
Why?
Caffeine
1
1990
67
0.010
Why?
Benzamides
1
1990
114
0.010
Why?
Cardiovascular Diseases
1
2002
1969
0.010
Why?
Adenosine Triphosphate
1
1990
280
0.010
Why?
Oxygen
1
1993
557
0.000
Why?
Alcohol Drinking
1
1991
347
0.000
Why?
Vaccinia virus
1
1988
52
0.000
Why?
Surgical Wound Infection
1
1991
261
0.000
Why?
Histiocytic Sarcoma
1
1988
4
0.000
Why?
Transfusion Reaction
1
1988
40
0.000
Why?
Sex Factors
1
1991
1293
0.000
Why?
Spleen
1
1988
281
0.000
Why?
Haiti
1
1987
10
0.000
Why?
Nasopharyngeal Neoplasms
1
1987
58
0.000
Why?
Surgical Procedures, Operative
1
1988
183
0.000
Why?
Viral Vaccines
1
1988
338
0.000
Why?
Sarcoma, Kaposi
1
1987
118
0.000
Why?
Veterans
1
1996
1722
0.000
Why?
Immunotherapy
1
1988
685
0.000
Why?
Palliative Care
1
1987
440
0.000
Why?
Carcinoma, Hepatocellular
1
1987
949
0.000
Why?
HILSENBECK's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (1182)
Explore
_
Co-Authors (189)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_